Newsroom | 41190 results
Sorted by: Latest
-
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its second-quarter 2026 financial results on Thursday, July 30, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/167756971 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter’s website at www.bax...
-
Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2026 after market close on Thursday, July 30, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will...
-
The 30-Second Test for Ear Infections That Pays for Itself: New Urgent Care Study Uses Intellivisit Data to Validate the Case for Tympanometry
NASHVILLE, Tenn.--(BUSINESS WIRE)--Most doctors use the same tool to assess children’s ears as when their caregivers visited the pediatrician decades ago. The otoscope, the tool clinicians squint through when examining the ears, has remained essentially unchanged for more than 50 years. A new study in the Journal of Urgent Care Medicine (JUCM), built on 140,894 real-world Intellivisit encounters, examined a more accurate and less uncomfortable tool for ear exams — the tympanometer. The research...
-
VB Spine’s European Distribution Center Begins Shipping Orders Across Europe
NEW YORK--(BUSINESS WIRE)--VB Spine LLC (“VB Spine”), a global, family-owned spine company, today announced that its European Distribution Center began shipping orders across Europe this month; the distribution center began accepting orders on June 1, 2026. Now that the center is fully operational, it serves as the primary center for VB Spine product distribution to customers in Europe. “The center allows us to support our customers more effectively by reducing fulfillment and response times,”...
-
CoLab Launches 4.0 — Built for Human Decision-Makers in an AI-First World
ST. JOHN'S, Newfoundland and Labrador--(BUSINESS WIRE)--CoLab today launched CoLab 4.0, its biggest platform update of 2026, unifying AI, collaboration, desktop and enterprise capabilities....
-
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call to review the company's second quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will...
-
Auxilium Biotechnologies Achieves Historic Space Bioprinting Milestone, Successfully Bioprinting Kidney and Liver Tissues in Orbit for the First Time
SAN DIEGO--(BUSINESS WIRE)--Auxilium Biotechnologies successfully bioprinted kidney and liver tissues aboard the International Space Station (ISS) for the first time in history....
-
Elucid Announces First Patient Enrollment in AI-PREDICT, a Landmark International Study to Define Lesion-Level Cardiovascular Risk
BOSTON--(BUSINESS WIRE)--Elucid, an innovator in AI-powered coronary CT angiography (CCTA) analysis, today announced first patient enrollment in AI-PREDICT, a retrospective, international, multicenter study designed to establish a new lesion-centric paradigm for cardiovascular risk stratification. Enrollment is underway at three of more than 20 planned sites across the U.S., Europe, and Asia: Emory University, the Medical University of South Carolina, and Centro Cardiologico Monzino, Milan, led...
-
AccurKardia and Wellysis Sign Multi-Year Agreement to Provide Wellysis’ Turnkey Cardiac Monitoring Offering in the U.S. Market
NEW YORK & SEOUL--(BUSINESS WIRE)--AccurKardia, Inc., an ECG-led diagnostics software company, and Wellysis, a digital healthcare company and developer of the S-Patch wearable ECG monitor, today announced a multi-year agreement under which AccurKardia’s AccurECG 2.0 will power the analytics behind Wellysis’ turnkey cardiac monitoring offering in the U.S. The agreement, which was signed last week in Seoul, is the latest between the two companies.Under the agreement, Wellysis’ S-Patch wearable dev...
-
KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries
NEW YORK--(BUSINESS WIRE)--KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and...